ArticleCells2026
Orange-Derived Extracellular Vesicles: Characterization and Therapeutic Applications in Normal and Diabetic Wound Healing in In Vivo Models.
Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanistic Insights into Plant-Derived Exosomes, Their Cross-Kingdom Effects, and Potential Biomedical Applications in Skin Wounds Repair.Plants (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Extracellular vesicles (EVs) of human origin show promise for regenerative medicine and wound healing. However, they have limitations regarding scalability, variability, safety, and costs. Plant-derived EVs may represent a valid alternative. This study investigated the regenerative potential of EVs extracted from orange juice (oEVs). oEVs obtained by standard ultracentrifugation were compared with oEVs purified by tangential flow filtration (TFF), a scalable technique suitable for large-scale and regulatory-compliant manufacturing. Comparisons included size, morphology, pH, Zeta potential, protein and RNA content, Raman spectroscopy, and proteomic, metabolomic, and RNA sequencing. The regenerative potential of oEVs was tested in vitro, with cell migration, endothelial tube formation, and proliferation assays performed. Antioxidant ability was tested on endothelial cells stressed by hyperglycemia or pro-inflammatory cytokine cocktails. Next, oEVs were formulated with different hydrogels and tested at different doses on skin ulcers on healthy and diabetic mice. TFF oEVs showed the same physio-chemical characteristics and a comparable molecular content as those isolated by ultracentrifugation, confirming the path to scalability. In vitro oEVs promoted cell migration, formation of capillary-like structures, cell proliferation, and strong antioxidant activity. Moreover, oEVs effectively accelerated in vivo wound closure in healthy and diabetic mice. Thus, oEVs may provide a useful and cost-effective ingredient for improved and effective wound treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.